Ipsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Finds
By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....
Source: marketwatch.com